Spread the love“`html JavaScript is the backbone of modern web functionality. Without it, many websites would be nothing more than static pages with basic information. If you’ve ever encountered a ...
The network will collectively negotiate rates with insurance companies and push for lower medical equipment costs. The move ...
The ads mark a return to "gay vague." But future queer representation on TV could get tougher, as the political climate ...
Justin Gaethje def. Ilia Topuria via TKO, Round 4 . Topuria was stopped on the stool! What a tremendous win for Gaethje!
With short-form video now dominant on social media, researchers are racing to understand how the highly engaging, algorithm-driven format may be reshaping the brain. Subscribe to read this story ...
The Special Intensive Revision (SIR) enumeration form is now available online, with the entire process managed directly by the Election Commission of India (ECI). Voters can simply click the dedicated ...
The Special Intensive Revision (SIR) process is a major activity of the Election Commission of India to keep electoral rolls accurate, up to date, and free of errors, in advance of major elections. As ...
SIR in Bengal: All voters, who are away from West Bengal, can now fill up the enumeration forms online. The online forms for Special Intensive Revision (SIR) have been made live following a brief ...
SIR in West Bengal 2025: If you are a voter and plan to vote in the West Bengal Assembly Elections 2026, you must remember that the Special Intensive Revision (SIR) 2025 of the electoral roll has ...
Starting October 1, 2025, foreign nationals and OCI cardholders must submit a mandatory e-arrival card before immigration in India. This digital initiative by the Bureau of Immigration aims to ...
Note: if you are looking for the newer, read-write version of this tool that supports non-public S3 buckets then please visit the S3 Explorer (v2 alpha) page. AWS ...
In an Aug. 7 earnings call, Eli Lilly CEO David Ricks told investors that the company plans to submit the drug, orforglipron, to the FDA for approval by the end of the year. Dan Skovronsky, chief ...